Walgreens Boots Alliance, Inc. (WBA) EV/EBITDA Ratio: N/A
The EV/EBITDA ratio for Walgreens Boots Alliance, Inc. (WBA) is N/A as of Saturday, June 13, 2026.
WBA EV/EBITDA Ratio Chart
WBA Average EV/EBITDA Ratio Chart
WBA EV/EBITDA Ratio Metrics
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
21.34x
EV/EBITDA RATIO AVG 3Y
19.40x
EV/EBITDA RATIO AVG 5Y
19.09x
EV/EBITDA RATIO AVG 10Y
15.56x
EV/EBITDA RATIO AVG 15Y
12.94x
EV/EBITDA RATIO AVG 20Y
13.26x
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
WBA Competitors' EV/EBITDA Ratio
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Walgreens Boots Alliance, Inc. (WBA) | $10.37B | N/A | 21.34x | 19.40x | 19.09x |
| Baxter International Inc. (BAX) | $10.77B | 24.95x | 20.34x | 19.12x | 19.11x |
| Charles River Laboratories International, Inc. (CRL) | $9.03B | 41.45x | 24.46x | 17.37x | 18.48x |
| Tempus AI, Inc. (TEM) | $8.35B | N/A | N/A | N/A | N/A |
| Align Technology, Inc. (ALGN) | $12.52B | 13.57x | 13.18x | 20.32x | 25.99x |
| Bio-Rad Laboratories, Inc. (BIO) | $7.73B | 18.27x | 11.86x | 62.18x | 32.77x |
| The Cooper Companies, Inc. (COO) | $13.24B | 17.97x | 15.95x | 20.14x | 21.92x |
| Solventum Corporation (SOLV) | $13.66B | 6.67x | 10.13x | 10.29x | 10.29x |
| Hims & Hers Health, Inc. (HIMS) | $5.98B | 234.03x | 77.19x | 128.21x | 128.21x |
| Hologic, Inc. (HOLX) | $16.97B | 17.28x | 15.01x | 15.35x | 12.41x |
Walgreens Boots Alliance, Inc. EV/EBITDA Ratio Formula & Definition
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Walgreens Boots Alliance, Inc. EV/EBITDA Ratio FAQ
- What is the EV/EBITDA ratio for Walgreens Boots Alliance, Inc. (WBA)?
- The EV/EBITDA ratio for WBA stock is N/A.
- What is the TTM average EV/EBITDA ratio for Walgreens Boots Alliance, Inc. (WBA)?
- The TTM average EV/EBITDA ratio for WBA stock is 21.34x.
- What is the 3Y average EV/EBITDA ratio for Walgreens Boots Alliance, Inc. (WBA)?
- The 3Y average EV/EBITDA ratio for WBA stock is 19.40x.
- What is the 5Y average EV/EBITDA ratio for Walgreens Boots Alliance, Inc. (WBA)?
- The 5Y average EV/EBITDA ratio for WBA stock is 19.09x.
- What is the 10Y average EV/EBITDA ratio for Walgreens Boots Alliance, Inc. (WBA)?
- The 10Y average EV/EBITDA ratio for WBA stock is 15.56x.
- What is the 15Y average EV/EBITDA ratio for Walgreens Boots Alliance, Inc. (WBA)?
- The 15Y average EV/EBITDA ratio for WBA stock is 12.94x.
- What is the 20Y average EV/EBITDA ratio for Walgreens Boots Alliance, Inc. (WBA)?
- The 20Y average EV/EBITDA ratio for WBA stock is 13.26x.
Walgreens Boots Alliance, Inc. EV/EBITDA Ratio History
| DATE | EV/EBITDA RATIO |
|---|---|
| 2024-03-27 | 20.96x |
| 2024-03-26 | 20.78x |
| 2024-03-25 | 20.82x |
| 2024-03-22 | 20.80x |
| 2024-03-21 | 20.88x |
| 2024-03-20 | 20.98x |
| 2024-03-19 | 20.85x |
| 2024-03-18 | 20.84x |
| 2024-03-15 | 20.89x |
| 2024-03-14 | 20.82x |
| 2024-03-13 | 20.97x |
| 2024-03-12 | 21.05x |
| 2024-03-11 | 21.14x |
| 2024-03-08 | 21.01x |
| 2024-03-07 | 20.93x |
| 2024-03-06 | 20.91x |
| 2024-03-05 | 20.95x |
| 2024-03-04 | 20.80x |
| 2024-03-01 | 21.12x |
| 2024-02-29 | 21.04x |
| 2024-02-28 | 21.01x |
| 2024-02-27 | 21.17x |
| 2024-02-26 | 20.95x |
| 2024-02-23 | 21.21x |
| 2024-02-22 | 21.15x |
| 2024-02-21 | 21.22x |
| 2024-02-20 | 21.41x |
| 2024-02-16 | 21.30x |
| 2024-02-15 | 21.41x |
| 2024-02-14 | 21.14x |
| 2024-02-13 | 21.14x |
| 2024-02-12 | 21.53x |
| 2024-02-09 | 21.39x |
| 2024-02-08 | 21.50x |
| 2024-02-07 | 21.59x |
| 2024-02-06 | 21.70x |
| 2024-02-05 | 21.36x |
| 2024-02-02 | 21.53x |
| 2024-02-01 | 21.75x |
| 2024-01-31 | 21.51x |
| 2024-01-30 | 21.57x |
| 2024-01-29 | 21.56x |
| 2024-01-26 | 21.60x |
| 2024-01-25 | 21.70x |
| 2024-01-24 | 21.43x |
| 2024-01-23 | 21.51x |
| 2024-01-22 | 21.50x |
| 2024-01-19 | 21.30x |
| 2024-01-18 | 21.36x |
| 2024-01-17 | 21.36x |
| 2024-01-16 | 21.61x |
| 2024-01-12 | 21.75x |
| 2024-01-11 | 22.02x |
| 2024-01-10 | 22.25x |
| 2024-01-09 | 22.49x |
| 2024-01-08 | 22.59x |
| 2024-01-05 | 22.37x |
| 2024-01-04 | 22.10x |
| 2023-01-04 | 10.44x |
| 2023-01-03 | 10.40x |
| 2022-12-30 | 10.42x |
| 2022-12-29 | 10.43x |
| 2022-12-28 | 10.45x |
| 2022-12-27 | 10.55x |
| 2022-12-23 | 10.59x |
| 2022-12-22 | 10.57x |
| 2022-12-21 | 10.59x |
| 2022-12-20 | 10.71x |
| 2022-12-19 | 10.69x |
| 2022-12-16 | 10.65x |
| 2022-12-15 | 10.71x |
| 2022-12-14 | 10.86x |
| 2022-12-13 | 10.92x |
| 2022-12-12 | 10.92x |
| 2022-12-09 | 10.84x |
| 2022-12-08 | 10.90x |
| 2022-12-07 | 10.87x |
| 2022-12-06 | 10.86x |
| 2022-12-05 | 10.94x |
| 2022-12-02 | 10.98x |
| 2022-12-01 | 10.96x |
| 2022-11-30 | 10.98x |
| 2022-11-29 | 10.92x |
| 2022-11-28 | 10.89x |
| 2022-11-25 | 11.00x |
| 2022-11-23 | 11.02x |
| 2022-11-22 | 11.02x |
| 2022-11-21 | 10.86x |
| 2022-11-18 | 10.74x |
| 2022-11-17 | 10.80x |
| 2022-11-16 | 10.83x |
| 2022-11-15 | 10.87x |
| 2022-11-14 | 10.85x |
| 2022-11-11 | 10.95x |
| 2022-11-10 | 10.57x |
| 2022-11-09 | 10.36x |
| 2022-11-08 | 10.55x |
| 2022-11-07 | 10.59x |
| 2022-11-04 | 10.38x |
| 2022-11-03 | 10.20x |
| 2022-11-02 | 10.21x |
| 2022-11-01 | 10.27x |
| 2022-10-31 | 10.30x |
| 2022-10-28 | 10.31x |
| 2022-10-27 | 10.19x |
| 2022-10-26 | 10.17x |
| 2022-10-25 | 10.17x |
| 2022-10-24 | 10.06x |
| 2022-10-21 | 10.00x |
| 2022-10-20 | 9.88x |
| 2022-10-19 | 9.88x |
| 2022-10-18 | 9.84x |
| 2022-10-17 | 9.83x |
| 2022-10-14 | 9.86x |
| 2022-10-13 | 9.92x |
| 2022-10-12 | 7.32x |
| 2022-10-11 | 7.39x |
| 2022-10-10 | 7.31x |
| 2022-10-07 | 7.18x |
| 2022-10-06 | 7.35x |
| 2022-10-05 | 7.44x |
| 2022-10-04 | 7.47x |
| 2022-10-03 | 7.37x |
| 2022-09-30 | 7.27x |
| 2022-09-29 | 7.28x |
| 2022-09-28 | 7.45x |
| 2022-09-27 | 7.37x |
| 2022-09-26 | 7.40x |
| 2022-09-23 | 7.41x |
| 2022-09-22 | 7.46x |
| 2022-09-21 | 7.47x |
| 2022-09-20 | 7.53x |
| 2022-09-19 | 7.54x |
| 2022-09-16 | 7.56x |
| 2022-09-15 | 7.55x |
| 2022-09-14 | 7.61x |
| 2022-09-13 | 7.60x |
| 2022-09-12 | 7.80x |
| 2022-09-09 | 7.76x |
| 2022-09-08 | 7.73x |
| 2022-09-07 | 7.74x |
| 2022-09-06 | 7.66x |
| 2022-09-02 | 7.66x |
| 2022-09-01 | 7.66x |
| 2022-08-31 | 7.64x |
| 2022-08-30 | 7.65x |
| 2022-08-29 | 7.73x |
| 2022-08-26 | 7.73x |
| 2022-08-25 | 7.81x |
| 2022-08-24 | 7.81x |
| 2022-08-23 | 7.88x |
| 2022-08-22 | 7.86x |
| 2022-08-19 | 7.96x |
| 2022-08-18 | 7.96x |
| 2022-08-17 | 8.22x |
| 2022-08-16 | 8.34x |
| 2022-08-15 | 8.24x |
| 2022-08-12 | 8.20x |
| 2022-08-11 | 8.14x |
| 2022-08-10 | 8.13x |
| 2022-08-09 | 8.05x |
| 2022-08-08 | 8.08x |
| 2022-08-05 | 8.03x |
| 2022-08-04 | 8.03x |
| 2022-08-03 | 8.05x |
| 2022-08-02 | 8.04x |
| 2022-08-01 | 8.12x |
| 2022-07-29 | 8.10x |
| 2022-07-28 | 8.08x |
| 2022-07-27 | 8.06x |
| 2022-07-26 | 8.02x |
| 2022-07-25 | 8.01x |
| 2022-07-22 | 8.00x |
| 2022-07-21 | 7.98x |
| 2022-07-20 | 8.03x |
| 2022-07-19 | 7.99x |
| 2022-07-18 | 7.97x |
| 2022-07-15 | 7.94x |
| 2022-07-14 | 7.82x |
| 2022-07-13 | 7.86x |
| 2022-07-12 | 7.93x |
| 2022-07-11 | 7.88x |
| 2022-07-08 | 7.89x |
| 2022-07-07 | 7.96x |
| 2022-07-06 | 7.91x |
| 2022-07-05 | 7.99x |
| 2022-07-01 | 7.99x |
| 2022-06-30 | 7.92x |
| 2022-06-29 | 7.25x |
| 2022-06-28 | 7.26x |
| 2022-06-27 | 7.37x |
| 2022-06-24 | 7.32x |
| 2022-06-23 | 7.26x |
| 2022-06-22 | 7.22x |
| 2022-06-21 | 7.19x |
| 2022-06-17 | 7.12x |
| 2022-06-16 | 7.15x |
| 2022-06-15 | 7.24x |
| 2022-06-14 | 7.20x |
| 2022-06-13 | 7.20x |
| 2022-06-10 | 7.31x |
| 2022-06-09 | 7.33x |
| 2022-06-08 | 7.41x |
| 2022-06-07 | 7.44x |
| 2022-06-06 | 7.48x |
| 2022-06-03 | 7.46x |
| 2022-06-02 | 7.48x |
| 2022-06-01 | 7.47x |
| 2022-05-31 | 7.52x |
| 2022-05-27 | 7.51x |
| 2022-05-26 | 7.45x |
| 2022-05-25 | 7.40x |
| 2022-05-24 | 7.36x |
| 2022-05-23 | 7.37x |
| 2022-05-20 | 7.26x |
| 2022-05-19 | 7.23x |
| 2022-05-18 | 7.28x |
| 2022-05-17 | 7.61x |
| 2022-05-16 | 7.54x |
| 2022-05-13 | 7.49x |
| 2022-05-12 | 7.46x |
| 2022-05-11 | 7.47x |
| 2022-05-10 | 7.47x |
| 2022-05-09 | 7.52x |
| 2022-05-06 | 7.53x |
| 2022-05-05 | 7.51x |
| 2022-05-04 | 7.57x |
| 2022-05-03 | 7.44x |
| 2022-05-02 | 7.40x |
| 2022-04-29 | 7.39x |
| 2022-04-28 | 7.58x |
| 2022-04-27 | 7.55x |
| 2022-04-26 | 7.61x |
| 2022-04-25 | 7.65x |
| 2022-04-22 | 7.67x |
| 2022-04-21 | 7.78x |
| 2022-04-20 | 7.76x |
| 2022-04-19 | 7.67x |
| 2022-04-18 | 7.58x |
| 2022-04-14 | 7.60x |
| 2022-04-13 | 7.58x |
| 2022-04-12 | 7.55x |
| 2022-04-11 | 7.57x |
| 2022-04-08 | 7.66x |
| 2022-04-07 | 7.63x |
| 2022-04-06 | 7.56x |
| 2022-04-05 | 7.49x |
| 2022-04-04 | 7.48x |
| 2022-04-01 | 7.52x |
| 2022-03-31 | 7.60x |
| 2022-03-30 | 7.70x |
| 2022-03-29 | 7.73x |
| 2022-03-28 | 7.68x |
| 2022-03-25 | 7.67x |
| 2022-03-24 | 7.66x |
| 2022-03-23 | 7.64x |
| 2022-03-22 | 7.70x |
| 2022-03-21 | 7.69x |
| 2022-03-18 | 7.69x |
| 2022-03-17 | 7.70x |
Showing the most recent 260 of 4,784 data points. The chart above shows the full history.
Related Metrics
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc., established in 1901 and based in Deerfield, Illinois, operates as a leading global retailer focused on pharmacy, health, and beauty products. Its business activities are organized into two primary divisions: the United States and International. In the United States, the company dispenses prescription drugs and offers a diverse selection of retail goods. This includes items for health, wellness, beauty, and personal care, alongside general merchandise and consumable products, all available through its extensive network of retail drugstores. The U.S. segment also provides specialized central pharmacy services and mail delivery options for prescriptions. As of August 31, 2021, this division managed 8,965 retail outlets under the Walgreens and Duane Reade banners, complemented by five specialty pharmacies. The International segment focuses on the sale of prescription medications, health and wellness items, beauty products, personal care essentials, and other consumer goods. These are sold through its pharmacy-centric health and beauty retail locations, optical practices, its online platform boots.com, and an integrated mobile application. Additionally, this segment engages in pharmaceutical wholesale and distribution operations within Germany. By August 31, 2021, the international portfolio included 4,031 retail stores operating under brands such as Boots, Benavides, and Ahumada, located across countries including the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. It also oversaw 548 optical practices, with 160 of these operating as franchises.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Timothy C. Wentworth